Niloofar Rahmani

Array ( [id] => 9719693 [patent_doc_number] => 20140255392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'SUBSTITUTED IMIDAZOPYRIDINES AND INTERMEDIATES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/110105 [patent_app_country] => US [patent_app_date] => 2012-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78214 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153699 [patent_doc_number] => 08586605 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Fused amino pyridine as HSP90 inhibitors' [patent_app_type] => utility [patent_app_number] => 13/424780 [patent_app_country] => US [patent_app_date] => 2012-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45648 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13424780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9710888 [patent_doc_number] => 08835456 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-09-16 [patent_title] => 'NS5A inhibitors useful for treating HCV' [patent_app_type] => utility [patent_app_number] => 13/423935 [patent_app_country] => US [patent_app_date] => 2012-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12674 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13423935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8336102 [patent_doc_number] => 20120202807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'AZABICYCLOALKANE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN THERAPY' [patent_app_type] => utility [patent_app_number] => 13/422296 [patent_app_country] => US [patent_app_date] => 2012-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11521 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13422296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8265932 [patent_doc_number] => 20120165366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'COMPOUNDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/413537 [patent_app_country] => US [patent_app_date] => 2012-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15069 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13413537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8453832 [patent_doc_number] => 20120264779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'QUINOLINONE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 13/409506 [patent_app_country] => US [patent_app_date] => 2012-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25843 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13409506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10838061 [patent_doc_number] => 08865735 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-21 [patent_title] => 'Solid forms of a pharmaceutically active substance' [patent_app_type] => utility [patent_app_number] => 13/817124 [patent_app_country] => US [patent_app_date] => 2012-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 10165 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10838061 [patent_doc_number] => 08865735 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-21 [patent_title] => 'Solid forms of a pharmaceutically active substance' [patent_app_type] => utility [patent_app_number] => 13/817124 [patent_app_country] => US [patent_app_date] => 2012-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 10165 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10838061 [patent_doc_number] => 08865735 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-21 [patent_title] => 'Solid forms of a pharmaceutically active substance' [patent_app_type] => utility [patent_app_number] => 13/817124 [patent_app_country] => US [patent_app_date] => 2012-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 10165 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10838061 [patent_doc_number] => 08865735 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-21 [patent_title] => 'Solid forms of a pharmaceutically active substance' [patent_app_type] => utility [patent_app_number] => 13/817124 [patent_app_country] => US [patent_app_date] => 2012-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 10165 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9455265 [patent_doc_number] => 08716273 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => 'N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy' [patent_app_type] => utility [patent_app_number] => 13/370956 [patent_app_country] => US [patent_app_date] => 2012-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35877 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13370956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9295308 [patent_doc_number] => 20140038942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'RORgammaT INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/983818 [patent_app_country] => US [patent_app_date] => 2012-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30365 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13983818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9455264 [patent_doc_number] => 08716272 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => 'N-(amino-heteroaryI)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy' [patent_app_type] => utility [patent_app_number] => 13/370940 [patent_app_country] => US [patent_app_date] => 2012-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35889 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13370940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10898176 [patent_doc_number] => 08921389 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase' [patent_app_type] => utility [patent_app_number] => 13/983025 [patent_app_country] => US [patent_app_date] => 2012-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 113978 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13983025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9175074 [patent_doc_number] => 20130317059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING PYRIDONE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/980819 [patent_app_country] => US [patent_app_date] => 2012-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22738 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9937662 [patent_doc_number] => 08987473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Ring-fused compound' [patent_app_type] => utility [patent_app_number] => 13/982200 [patent_app_country] => US [patent_app_date] => 2012-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 90726 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13982200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199448 [patent_doc_number] => 20120122892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'CHEMICAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/357848 [patent_app_country] => US [patent_app_date] => 2012-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29709 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122892.pdf [firstpage_image] =>[orig_patent_app_number] => 13357848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199315 [patent_doc_number] => 20120122810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'Fused Pentacyclic Polyethers' [patent_app_type] => utility [patent_app_number] => 13/356312 [patent_app_country] => US [patent_app_date] => 2012-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11263 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122810.pdf [firstpage_image] =>[orig_patent_app_number] => 13356312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8290454 [patent_doc_number] => 20120178776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'DIHYDRONAPHTHYRIDINYL(ORGANO)METHANONE ANALOGS AS POSITIVE ALLOSTERIC MGLUR5 MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/349476 [patent_app_country] => US [patent_app_date] => 2012-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 53393 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13349476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413660 [patent_doc_number] => 08697697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Pyrazole derivatives as ERK inhibitors' [patent_app_type] => utility [patent_app_number] => 13/977948 [patent_app_country] => US [patent_app_date] => 2012-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8407 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13977948 [rel_patent_id] =>[rel_patent_doc_number] =>)